Stocks
News
ETFs
Economy
Currencies
Press Releases
Tvardi Therapeutics, Inc. - Common Stock (TVRD)
Last Price
6.6100
Change
-34.9900 (-84.11%)
NASDAQ
· Last Trade: Oct 13th, 2:07 PM EDT
Quote
News
Press Releases
Chart
Historical
FAQ
About
Competitors
Gold Rises Over 3%; Tvardi Therapeutics Shares Plunge
benzinga.com
Via
Benzinga
· October 13, 2025
12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com
Via
Benzinga
· October 13, 2025
Dow Surges 1%; Fastenal Shares Fall After Q3 Results
benzinga.com
Via
Benzinga
· October 13, 2025
12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com
Via
Benzinga
· October 13, 2025
Why Did Tvardi Therapeutics Stock Plummet 87% Pre-Market Today?
stocktwits.com
The company said that its investigational drug did not meet its goal in a study, and no statistically significant differences between placebo and treatment arms were observed after preliminary review of exploratory efficacy.
Via
Stocktwits
· October 13, 2025
Tvardi Posts Q2 Net Income Turnaround
fool.com
Via
The Motley Fool
· August 14, 2025
Recently Listed Tvardi Therapeutics' Lead Drug 'Positioned To Drive Broad Improvement', Analyst Sees Over 150% Stock Upside
benzinga.com
Tvardi advances fibrosis drug TTI-101 in IPF and liver cancer as Piper initiates with $78 target; merger boosts cash runway into late 2026.
Via
Benzinga
· June 12, 2025
This Modine Manufacturing Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
benzinga.com
Via
Benzinga
· June 12, 2025
12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com
Via
Benzinga
· May 2, 2025
12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com
Via
Benzinga
· April 25, 2025
Why Coursera Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket
benzinga.com
Via
Benzinga
· April 25, 2025
